Athenex announces $50 million interest financing with Sagard Healthcare Royalty Partners
BUFFALO, N.Y., August 6, 2020 (GLOBE NEWSWIRE) – Athenex, Inc. (Nasdaq: ATNX), a biopharmaceutical company committed to the discovery of Array..
Athenex announces $50 million interest financing with Sagard Healthcare Royalty Partners Read More »